183 related articles for article (PubMed ID: 29753032)
1. Enhancement of Cutaneous Wound Healing by Dsg2 Augmentation of uPAR Secretion.
Cooper F; Overmiller AM; Loder A; Brennan-Crispi DM; McGuinn KP; Marous MR; Freeman TA; Riobo-Del Galdo NA; Siracusa LD; Wahl JK; Mahoney MG
J Invest Dermatol; 2018 Nov; 138(11):2470-2479. PubMed ID: 29753032
[TBL] [Abstract][Full Text] [Related]
2. Suprabasal Dsg2 expression in transgenic mouse skin confers a hyperproliferative and apoptosis-resistant phenotype to keratinocytes.
Brennan D; Hu Y; Joubeh S; Choi YW; Whitaker-Menezes D; O'Brien T; Uitto J; Rodeck U; Mahoney MG
J Cell Sci; 2007 Mar; 120(Pt 5):758-71. PubMed ID: 17284515
[TBL] [Abstract][Full Text] [Related]
3. AP-1-controlled hepatocyte growth factor activation promotes keratinocyte migration via CEACAM1 and urokinase plasminogen activator/urokinase plasminogen receptor.
Schnickmann S; Camacho-Trullio D; Bissinger M; Eils R; Angel P; Schirmacher P; Szabowski A; Breuhahn K
J Invest Dermatol; 2009 May; 129(5):1140-8. PubMed ID: 19020551
[TBL] [Abstract][Full Text] [Related]
4. uPAR-deficient mouse keratinocytes fail to produce EGFR-dependent laminin-5, affecting migration in vivo and in vitro.
D'Alessio S; Gerasi L; Blasi F
J Cell Sci; 2008 Dec; 121(Pt 23):3922-32. PubMed ID: 19001498
[TBL] [Abstract][Full Text] [Related]
5. Crosstalk between Desmoglein 2 and Patched 1 accelerates chemical-induced skin tumorigenesis.
Brennan-Crispi DM; Hossain C; Sahu J; Brady M; Riobo NA; Mahoney MG
Oncotarget; 2015 Apr; 6(11):8593-605. PubMed ID: 25871385
[TBL] [Abstract][Full Text] [Related]
6. Increased migration of murine keratinocytes under hypoxia is mediated by induction of urokinase plasminogen activator.
Daniel RJ; Groves RW
J Invest Dermatol; 2002 Dec; 119(6):1304-9. PubMed ID: 12485432
[TBL] [Abstract][Full Text] [Related]
7. Sphingosylphosphorylcholine stimulates proliferation and upregulates cell surface-associated plasminogen activator activity in cultured human keratinocytes.
Wakita H; Matsushita K; Nishimura K; Tokura Y; Furukawa F; Takigawa M
J Invest Dermatol; 1998 Mar; 110(3):253-8. PubMed ID: 9506444
[TBL] [Abstract][Full Text] [Related]
8. Epithelial tissue-type plasminogen activator expression, unlike that of urokinase, its receptor, and plasminogen activator inhibitor-1, is increased in chronic venous ulcers.
Weckroth M; Vaheri A; Virolainen S; Saarialho-Kere U; Jahkola T; Sirén V
Br J Dermatol; 2004 Dec; 151(6):1189-96. PubMed ID: 15606514
[TBL] [Abstract][Full Text] [Related]
9. A role for caveolin-1 in desmoglein binding and desmosome dynamics.
Brennan D; Peltonen S; Dowling A; Medhat W; Green KJ; Wahl JK; Del Galdo F; Mahoney MG
Oncogene; 2012 Mar; 31(13):1636-48. PubMed ID: 21841821
[TBL] [Abstract][Full Text] [Related]
10. The receptor for urokinase-type plasminogen activator is expressed by keratinocytes at the leading edge during re-epithelialization of mouse skin wounds.
Rømer J; Lund LR; Eriksen J; Pyke C; Kristensen P; Danø K
J Invest Dermatol; 1994 Apr; 102(4):519-22. PubMed ID: 8151132
[TBL] [Abstract][Full Text] [Related]
11. c-Src/Cav1-dependent activation of the EGFR by Dsg2.
Overmiller AM; McGuinn KP; Roberts BJ; Cooper F; Brennan-Crispi DM; Deguchi T; Peltonen S; Wahl JK; Mahoney MG
Oncotarget; 2016 Jun; 7(25):37536-37555. PubMed ID: 26918609
[TBL] [Abstract][Full Text] [Related]
12. Desmoglein 2 modulates extracellular vesicle release from squamous cell carcinoma keratinocytes.
Overmiller AM; Pierluissi JA; Wermuth PJ; Sauma S; Martinez-Outschoorn U; Tuluc M; Luginbuhl A; Curry J; Harshyne LA; Wahl JK; South AP; Mahoney MG
FASEB J; 2017 Aug; 31(8):3412-3424. PubMed ID: 28438789
[TBL] [Abstract][Full Text] [Related]
13. Differential effects of acute and chronic wound fluids on urokinase-type plasminogen activator, urokinase-type plasminogen activator receptor, and tissue-type plasminogen activator in cultured human keratinocytes and fibroblasts.
Weckroth M; Vaheri A; Myöhänen H; Tukiainen E; Sirén V
Wound Repair Regen; 2001; 9(4):314-22. PubMed ID: 11679140
[TBL] [Abstract][Full Text] [Related]
14. Retinoic acid upregulates the plasminogen activator system in human epidermal keratinocytes.
Braungart E; Magdolen V; Degitz K
J Invest Dermatol; 2001 May; 116(5):778-84. PubMed ID: 11348470
[TBL] [Abstract][Full Text] [Related]
15. Systemic and topical administration of spermidine accelerates skin wound healing.
Ito D; Ito H; Ideta T; Kanbe A; Ninomiya S; Shimizu M
Cell Commun Signal; 2021 Mar; 19(1):36. PubMed ID: 33752688
[TBL] [Abstract][Full Text] [Related]
16. Increased expression of Dsg2 in malignant skin carcinomas: A tissue-microarray based study.
Brennan D; Mahoney MG
Cell Adh Migr; 2009; 3(2):148-54. PubMed ID: 19458482
[TBL] [Abstract][Full Text] [Related]
17. Hyperglycemia is associated with lower levels of urokinase-type plasminogen activator and urokinase-type plasminogen activator receptor in wound fluid.
Akinci B; Terzi C; Sevindik G; Yuksel F; Tunc UA; Tunali S; Yesil S
J Diabetes Complications; 2014; 28(6):844-9. PubMed ID: 25179235
[TBL] [Abstract][Full Text] [Related]
18. Promotion of Wound Healing by an Agonist of Adenosine A2A Receptor Is Dependent on Tissue Plasminogen Activator.
Montesinos MC; Desai-Merchant A; Cronstein BN
Inflammation; 2015 Dec; 38(6):2036-41. PubMed ID: 25991438
[TBL] [Abstract][Full Text] [Related]
19. The suppressor of cytokine signaling (SOCS)-3 determines keratinocyte proliferative and migratory potential during skin repair.
Linke A; Goren I; Bösl MR; Pfeilschifter J; Frank S
J Invest Dermatol; 2010 Mar; 130(3):876-85. PubMed ID: 19924142
[TBL] [Abstract][Full Text] [Related]
20. Urokinase-type plasminogen activator and its receptor synergize to promote pathogenic proteolysis.
Zhou HM; Nichols A; Meda P; Vassalli JD
EMBO J; 2000 Sep; 19(17):4817-26. PubMed ID: 10970872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
